David Ross

15.9k total citations · 3 hit papers
226 papers, 13.4k citations indexed

About

David Ross is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, David Ross has authored 226 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 98 papers in Toxicology and 55 papers in Organic Chemistry. Recurrent topics in David Ross's work include Bioactive Compounds and Antitumor Agents (97 papers), Genomics, phytochemicals, and oxidative stress (72 papers) and Cancer therapeutics and mechanisms (36 papers). David Ross is often cited by papers focused on Bioactive Compounds and Antitumor Agents (97 papers), Genomics, phytochemicals, and oxidative stress (72 papers) and Cancer therapeutics and mechanisms (36 papers). David Ross collaborates with scholars based in United States, United Kingdom and Sweden. David Ross's co-authors include David Siegel, Shannon L. Winski, Neil W. Gibson, Peter Moldéus, Howard D. Beall, Jadwiga K. Kepa, Gerald M. Cohen, Adil Anwar, Donna L. Dehn and Terrence J. Monks and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Ross

223 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quinone chemistry and toxicity

1992 644 citations David Ross et al. profile →
NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

2000 527 citations David Ross, Jadwiga K. Kepa et al. Chemico-Biological Interactions profile →
The diverse functionality of NQO1 and its roles in redox control

2021 312 citations David Ross, David Siegel Redox Biology profile →

Peers

David Ross

TOXIC

PHARM

Anil K. Jaiswal United States

T.M. Penning United States

Terrence J. Monks United States

Albena T. Dinkova‐Kostova United States

Michael A. Trush United States

Roderick H. Dashwood United States

Yuesheng Zhang United States

Fulvio Ursini Italy

Hartmut Kühn Germany

Sanjay Srivastava United States

Anil K. Jaiswal United States

David Ross

10.8k ×1.3

1.3k ×0.4

TOXIC

1.7k ×0.6

1.4k ×0.9

1.3k ×1.4

PHARM

Citations per year, relative to David Ross David Ross (= 1×) peers Anil K. Jaiswal

Countries citing papers authored by David Ross

Since Specialization

Citations

This map shows the geographic impact of David Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ross more than expected).

Fields of papers citing papers by David Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ross. The network helps show where David Ross may publish in the future.

Co-authorship network of co-authors of David Ross

This figure shows the co-authorship network connecting the top 25 collaborators of David Ross. A scholar is included among the top collaborators of David Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ross. David Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kitson, Russell R. A., et al.. (2024). Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry. Journal of Medicinal Chemistry. 67(20). 17946–17963. 7 indexed citations

Siegel, David, Peter S. Harris, Andrea Di Francesco, et al.. (2020). A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation. Redox Biology. 39. 101840–101840. 19 indexed citations

Yan, Chao, David Siegel, Marie A. Colucci, et al.. (2011). Mechanism‐Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein Inhibition. ChemBioChem. 12(8). 1203–1208. 18 indexed citations

Chan, Kok Meng, Nor Fadilah Rajab, David Siegel, et al.. (2010). Goniothalamin Induces Coronary Artery Smooth Muscle Cells Apoptosis: The p53-Dependent Caspase-2 Activation Pathway. Toxicological Sciences. 116(2). 533–548. 38 indexed citations

Siegel, David, Biehuoy Shieh, Chao Yan, Jadwiga K. Kepa, & David Ross. (2010). Role for NAD(P)H:quinone Oxidoreductase 1 and Manganese-Dependent Superoxide Dismutase in 17-(Allylamino)-17-demethoxygeldanamycin-Induced Heat Shock Protein 90 Inhibition in Pancreatic Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 336(3). 874–880. 18 indexed citations

Yan, Chao, Jadwiga K. Kepa, David Siegel, Ian J. Stratford, & David Ross. (2008). Dissecting the Role of Multiple Reductases in Bioactivation and Cytotoxicity of the Antitumor Agent 2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1). Molecular Pharmacology. 74(6). 1657–1665. 33 indexed citations

Reigan, Philip, Wenchang Guo, David Siegel, & David Ross. (2006). Molecular docking studies investigating the interaction of a series of benzoquinone ansamycin Hsp90 inhibitors with NAD(P)H:quinone oxidoreductase 1 (NQO1). Cancer Research. 66. 457–457. 1 indexed citations

Ross, David. (2005). Functions and distribution of NQO1 in human bone marrow: Potential clues to benzene toxicity. Chemico-Biological Interactions. 153-154. 137–146. 40 indexed citations

Bironaitė, Daiva, et al.. (2004). Stimulation of endothelial IL-8 (eIL-8) production and apoptosis by phenolic metabolites of benzene in HL-60 cells and human bone marrow endothelial cells. Chemico-Biological Interactions. 149(2-3). 177–188. 17 indexed citations

10.

Sarbia, Mario, David Siegel, David Ross, et al.. (2003). Association between NAD(P)H: Quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. International Journal of Cancer. 107(3). 381–386. 52 indexed citations

11.

Kepa, Jadwiga K. & David Ross. (2003). Differential expression of the antioxidant response element within the hNQO1 promoter in NSCLC versus SCLC. Biochemical and Biophysical Research Communications. 311(2). 446–453. 7 indexed citations

12.

Gustafson, Daniel L., David Siegel, Jeffrey C. Rastatter, et al.. (2003). Kinetics of NAD(P)H:Quinone Oxidoreductase I (NQO1) Inhibition by Mitomycin C in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1079–1086. 18 indexed citations

13.

Inayat‐Hussain, Salmaan H., et al.. (2000). Caspase-dependent and -independent mechanisms in apoptosis induced by hydroquinone and catechol metabolites of remoxipride in HL-60 cells. Chemico-Biological Interactions. 128(1). 51–63. 15 indexed citations

14.

Ross, David. (2000). THE ROLE OF METABOLISM AND SPECIFIC METABOLITES IN BENZENE-INDUCED TOXICITY: EVIDENCE AND ISSUES. Journal of Toxicology and Environmental Health. 61(5-6). 357–372. 154 indexed citations

15.

Claffey, David J., Dennis R. Koop, Raimund M. Peter, et al.. (1998). Oxidation of 1,3-butadiene to (R)- and (S)-butadiene monoxide by purified recombinant cytochrome P450 2E1 from rabbit, rat and human. Toxicology Letters. 95(2). 123–129. 15 indexed citations

16.

Ross, David, et al.. (1997). Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. British Journal of Cancer. 76(7). 852–854. 169 indexed citations

17.

Thompson, John A., et al.. (1995). Role of Cytochrome P450 in the Metabolism and Toxicity of Hydroperoxides in Isolated Rat Hepatocytes. Archives of Biochemistry and Biophysics. 323(2). 463–470. 6 indexed citations

18.

Siegel, David, Howard D. Beall, Masaji Kasai, et al.. (1992). Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry. 31(34). 7879–7885. 137 indexed citations

19.

Preusch, Peter C., David Siegel, Neil W. Gibson, & David Ross. (1991). A note on the inhibition of DT-diaphorase by dicoumarol. Free Radical Biology and Medicine. 11(1). 77–80. 67 indexed citations

20.

Ross, David. (1988). Glutathione, free radicals and chemotherapeutic agents. Pharmacology & Therapeutics. 37(2). 231–249. 366 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact